Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Roberto Gedaly

Clinical trials sponsored by Roberto Gedaly, explained in plain language.

Trials to join now! 1

New Once-Daily drug may better protect transplanted kidneys

Disease control Recruiting now

This study compares a once-daily anti-rejection drug (Envarsus XR) to a twice-daily drug (tacrolimus) in 78 adults receiving a first kidney transplant. The goal is to see if Envarsus XR reduces hidden rejection and improves immune system markers in the blood. Participants will be…

Phase: PHASE2, PHASE3 • Sponsor: Roberto Gedaly • Aim: Disease control

Last updated May 11, 2026 20:48 UTC